ANVISA registration 81816720090Valid until Mar 09, 2036HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV)
ANVISA Registration Number: 81816720090ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDAVIRCELL S.L.Risk Class IV
Device names
- Technical name
- HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV)
- Risk class
- Class IV
PT: HERPES VÍRUS (HHV 4) - VÍRUS EPSTEIN-BARR (EBV)
Registration details
- Registration Number
- 81816720090
- Process Number
- 25351114473202509
- CNPJ
- 31167508000102
Company information
- Registration Holder
- ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA
- Manufacturer
- VIRCELL S.L.
- Manufacturing Country
- Spain
PT: ESPANHA
Dates and status
- Publication Date
- Mar 09, 2026
- Validity
- 09/03/2036
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81816720090 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until Mar 09, 2036.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.